J
Jean-Francois J. DuFour
Publications - 3
Citations - 2606
Jean-Francois J. DuFour is an academic researcher. The author has contributed to research in topics: Ombitasvir & Dasabuvir. The author has an hindex of 2, co-authored 3 publications receiving 2332 citations.
Papers
More filters
EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma European Association for the Study of the Liver ⇑ , European Organisation for Research and Treatment of Cancer
Josep M. Llovet,Michel Ducreux,Riccardo Lencioni,Adrian M. Di Bisceglie,Jean-Francois J. DuFour,Tim F. Greten,Eric Raymond,Tania Roskams,Vincenzo Mazzaferro,Jordi Bruix,Massimo Colombo,Andrew X. Zhu +11 more
TL;DR: The purpose of this document is to assist physicians, patients, health-care providers, and health-policy makers from Europe and worldwide in the decision-making process according to evidencebased data.
Journal Article
Safety of ABT-450/r/Ombitasvir plus Dasabuvir With or Without Ribavirin in HCV Genotype 1-infected Patients >= 65 Years of Age: Results From Phase 2 and 3 Trials
Steven L. Flamm,Edward Gane,Jean-Francois J. DuFour,Vinod K. Rustgi,Vincent G. Bain,Darrell H. G. Crawford,Pietro Andreone,Tarek Hassanein,Włodzimierz Mazur,Sandra S. Lovell,Barbara Da Silva-Tillmann,Nancy S. Shulman,Massimo Puoti,Terry Box,Ira M. Jacobson +14 more
Journal Article
SVR12 Rate of 98.6% in 992 HCV Genotype 1b-Infected Patients Treated with ABT-450/r/Ombitasvir and Dasabuvir With or Without Ribavirin
Massimo Colombo,Ola Weiland,Daniel E. Cohen,Jean-Francois J. DuFour,Hendrik Reynaert,Moisés Diago,Erica Villa,Adrian Streinu-Cercel,Wangang Xie,Tolga Baykal,Jeffrey Enejosa,Eoin Coakley,Roger Trinh,Thomas Podsadecki +13 more